Lyell Immunopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. 

CEO
Lynn Seely
CEOLynn Seely
Employees
224
Employees224
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2018
Founded2018
Employees
224
Employees224

LYEL Key Statistics

Market cap
601.19M
Market cap601.19M
Price-Earnings ratio
-2.38
Price-Earnings ratio-2.38
Dividend yield
Dividend yield
Average volume
925.85K
Average volume925.85K
High today
$2.29
High today$2.29
Low today
$2.02
Low today$2.02
Open price
$2.04
Open price$2.04
Volume
1.18M
Volume1.18M
52 Week high
$3.97
52 Week high$3.97
52 Week low
$1.32
52 Week low$1.32
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.